Mitochondrial permeability transition pore inhibitor

This page covers all Mitochondrial permeability transition pore inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting mPTP.

Targets

mPTP

Phase 2 pipeline (1)

• KL1333 · Abliva AB · Oncology
  KL1333 is a small molecule that targets the mitochondrial permeability transition pore (mPTP) to induce cell death in cancer cells.